Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

耐信 - NMPA Drug Approval Details

Approvals/NMPA/Esomeprazole Magnesium Enteric-coated Tablets

Approved

化学药品

Esomeprazole Magnesium Enteric-coated Tablets

ASTRAZENECA UK LIMITED🇨🇳 National Medical Products Administration

Approval Date: Nov 16, 2022
Approval ID: 51fc969ee85dbddb
Company: ASTRAZENECA UK LIMITED
Type: 化学药品

Approval Details

Approval Id: 51fc969ee85dbddb
Approval Number: 国药准字HJ20181005
Generic Name: 艾司奥美拉唑镁肠溶片
Generic Name En: Esomeprazole Magnesium Enteric-coated Tablets
Trade Name: 耐信
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 20mg
Reg Date: 2022-11-16
Expired Date: 2027-11-15
Company Name: ASTRAZENECA UK LIMITED
Production Company Name: ASTRAZENECA AB
Company Detail Path: /organization/astrazeneca-uk-limited
Production Company Detail Path: /organization/astrazeneca-ab

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 16, 2022

Approval ID

51fc969ee85dbddb

Type

化学药品

Back to NMPA Approvals